Cargando…

Antiplatelet strategy during ad-hoc percutaneous coronary intervention in elective patients: how aggressive should we be?

Detalles Bibliográficos
Autores principales:	Selvarajah, Abi, Hermanides, Renicus S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bohn Stafleu van Loghum 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10602977/ https://www.ncbi.nlm.nih.gov/pubmed/37861974 http://dx.doi.org/10.1007/s12471-023-01825-9

Ejemplares similares

Current and Future Insights for Optimizing Antithrombotic Therapy to Reduce the Burden of Cardiovascular Ischemic Events in Patients with Acute Coronary Syndrome
por: Selvarajah, Abi, et al.
Publicado: (2022)

Commentary: Coronary revascularization: How should we do it?
por: Sotolongo, Alex, et al.
Publicado: (2020)

Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
por: ten Berg, Jurriën M, et al.
Publicado: (2001)

Single-staged transfemoral transcatheter aortic valve implantation and percutaneous coronary intervention with rotablation in complex coronary artery disease: a case report
por: Postma, Warner R, et al.
Publicado: (2018)

Noninvasive ventilation for acute lung injury: how often should we try, how often should we fail?
por: Garpestad, Erik, et al.
Publicado: (2006)

How should we address the pipeline problem?
por: Braun, Hillary J.
Publicado: (2016)

The Emergence of Human Coronavirus EMC: How Scared Should We Be?
por: Chan, Renee W. Y., et al.
Publicado: (2013)

How Should We Manage Iatrogenic Perforation Caused by Colonoscopy?
por: Kim, Eun Sun
Publicado: (2016)

Feasibility and safety of cangrelor in patients with suboptimal P2Y(12) inhibition undergoing percutaneous coronary intervention: the Dutch Cangrelor registry
por: Selvarajah, Abi, et al.
Publicado: (2021)

Ad hoc and Fast Forward: The Science of Hormesis Growth and Development
por: Mushak, Paul
Publicado: (2009)

Prehospital advanced trauma life support: how should we manage the airway, and who should do it?
por: Brambrink, Ansgar M, et al.
Publicado: (2004)

Goal-directed or goal-misdirected - how should we interpret the literature?
por: Roche, Anthony M, et al.
Publicado: (2010)

Ultra-protective tidal volume: how low should we go?
por: Costa, Eduardo LV, et al.
Publicado: (2013)

Coated Flow Diverters and Single Antiplatelet Treatment: Where are We?
por: Pierot, Laurent
Publicado: (2022)

Antiplatelet Therapy and Percutaneous Coronary Interventions
por: Davanzo, Rene Hameau, et al.
Publicado: (2021)

Venoarterial extracorporeal membrane oxygenation in elective high-risk percutaneous coronary intervention: a viable option?
por: Meuwese, C. L., et al.
Publicado: (2020)

Commentary: Pleurography: We can, but should we?
por: Benz, Cecilia, et al.
Publicado: (2021)

Commentary: Patient Perspectives on Artificial Intelligence; What have We Learned and How Should We Move Forward?
por: Camaradou, Jennifer Catherine Louise, et al.
Publicado: (2023)

How should we monitor the cardiovascular benefit of sodium–glucose cotransporter 2 inhibition?
por: Tanaka, Atsushi, et al.
Publicado: (2020)

Should we modulate the neonatal microbiome and what should be the goal?
por: van Best, Niels, et al.
Publicado: (2022)

Intensity of antiplatelet therapy and percutaneous coronary intervention
por: Aronow, Wilbert S
Publicado: (2009)

Treatment strategies in patients with diabetes and three‐vessel coronary disease: What should we choose?
por: Liang, Bo, et al.
Publicado: (2021)

Should We Be Afraid of Antiplatelet Treatment before Carotid Endarterectomy?
por: Sucu, Nehir, et al.
Publicado: (2018)

Comment on “Should we reframe how we think about physical activity and sedentary behavior measurement? Validity and reliability reconsidered”
por: Terwee, Caroline B., et al.
Publicado: (2016)

Exploring new insights in coronary lesion assessment and treatment in patients with diabetes mellitus: the impact of optical coherence tomography
por: Hommels, Tobias Michiel, et al.
Publicado: (2023)

Should we breathe quiet or noisy?
por: Putensen, Christian, et al.
Publicado: (2014)

Dual‐Antiplatelet Therapy After Percutaneous Coronary Intervention: How Short Is Too Short?
por: Mourikis, Philipp, et al.
Publicado: (2023)

Understanding environmental influences on nutrition and physical activity behaviors: where should we look and what should we count?
por: Ball, Kylie, et al.
Publicado: (2006)

How we should tailor the nodal staging for various types of lung cancer?
por: Watanabe, Shun-ichi
Publicado: (2020)

Breast cancer research: where we are and where we should go
por: Liu, Edison T
Publicado: (2000)

Income and antiplatelet adherence following percutaneous coronary intervention
por: LaRosa, Anna R., et al.
Publicado: (2022)

Should we go nuts about nuts?
por: Rohrmann, Sabine, et al.
Publicado: (2013)

Zika virus in the testes: should we be worried?
por: Wong, Gary, et al.
Publicado: (2017)

Vaccine safety concerns: Should we be changing the way we support immunization?
por: MacDonald, Noni E, et al.
Publicado: (2020)

Commentary: Just because we can, doesn't always mean we should
por: Nellis, Joseph R., et al.
Publicado: (2021)

Quantifying the added value of new biomarkers: how and how not
por: Cook, Nancy R.
Publicado: (2018)

Debate: Unstable angina - When should we intervene?
por: Kereiakes, Dean J
Publicado: (2000)

Novel Forms of Lipodystrophy: Why should we care?
por: Rother, Kristina I., et al.
Publicado: (2013)

Endotracheal tube leak: What should we do?
por: Gupta, Nishkarsh
Publicado: (2015)

NSTEMI treatment: should we always follow the guidelines?
por: van ’t Hof, A. W. J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hihpgp507ptbc0470rjlipdrnp